Meet Confirmed Speakers from the European Medicines Agency (EMA)
DIA Europe 2026 is the only event where you can hear from nearly all top executives at the EMA.
DIA Europe 2026 is a unique opportunity to hear directly from senior leaders and experts at the European Medicines Agency on topics shaping medicines regulation, clinical trials, and regulatory science in Europe.
At a pivotal time for healthcare and regulatory policy, EMA representatives will share insights into current priorities, emerging challenges, and the future of medicines development and oversight. Learn more about the EMA speakers participating in this year’s conference.
Stiina Aarum
Senior Scientific Specialist
Peter Arlett
Head Data Analytics and Methods Task Force
Priya Bahri
Senior Lead - Pharmacovigilance and Risk Management Guidance and Policy
Michael Berntgen
Head of Scientific Evidence Generation
Christelle Bouygues
Senior Regulatory Affairs Officer
Juan Garcia Burgos
Head of Public and Stakeholders Engagement Department
Melanie Carr
Head of Stakeholders and Communication
Marco Cavaleri
Head of Health Threats and Vaccines Strategy
Radhouane Cherif
Senior International Liaison
Emer Cooke
Executive Director
Emmanuel Cormier
Head of Regulatory Science and Innovation
Kevin Cunningam
PRIME Scientific Coordinator
Silvy Da Rocha
Scientific Administrator
Francesca Day
Head of Therapeutic Areas Department
Monica Dias
Head of Supply and Availability of Medicines and Medical Devices
Brian Dooley
Pharmaceutical Quality Senior Specialist
Falk Ehmann
Head of Innovation and Development Accelerator
Leonor Enes
Product Team Leder, Human Postauthorisation
Zaide Frias
Chief Digital Officer
Alberto Ganan
Head of Committees and Quality Assurance
Hilmar Hamann
Head of Information Management
Sabine Haubenreisser
Principal Scientific Administrator, Stakeholders and Communication Division
Heidi Janssen
Head of Therapies for Endocrine and Cardiovascular Diseases
Veronika Jekerle
Head of Pharmaceutical Quality, Quality and Safety, Human medicines
Dominik Karres
Scientific Officer
Evdokia Korakianiti
Head of Quality and Safety of Medicines
Kristina Larsson
Head of Orphan Medicines, Division for Human Medicines Evidence Generation
Florian Lasch
Biostatistics Specialist, Data Analytics and Methods Task Force
Alexis Nolte
Head of Human Medicines Division
Maria Victoria Palmi Reig
Senior International Affairs officer
Ana Zanoletty Perez
Head of Clinical Trials Transformation Workstream
Francesco Pignatti
Scientific Adviser for Oncology
Stefano Ponzano
Head of Translational sciences office at EMA
Stefanie Prilla
RWE Coordinator
Dolça Rogers
Quality Specialist, Pharmaceutical Quality Office
Elizabeth Scanlan
ePI Product Owner
Andrej Segec
Senior Epidemiology Specialist
Steffen Thirstrup
Chief Medical Officer
Ana Trullás Jimeno
Senior Scientific Specialist
Peter Twomey
Head of Inspections
Denise Umuhire
Pharmacoepidemiologist and Real-World Evidence Specialist
Patrice Verpillat
Head of the Real World Evidence (RWE) Workstream